Nestle Health Science Us Holdings, Inc. - Net Worth and Insider Trading
Nestle Health Science Us Holdings, Inc. Net Worth
The estimated net worth of Nestle Health Science Us Holdings, Inc. is at least $697 Million dollars as of 2024-09-20. Nestle Health Science Us Holdings, Inc. is the 10% Owner of Aimmune Therapeutics Inc and owns about 20,216,697 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $697 Million. Nestle Health Science Us Holdings, Inc. is also the 10% Owner of Axcella Health Inc and owns about 172,222 shares of Axcella Health Inc (AXLA) stock worth over $69,044. Details can be seen in Nestle Health Science Us Holdings, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nestle Health Science Us Holdings, Inc. has not made any transactions after 2020-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nestle Health Science Us Holdings, Inc.
Nestle Health Science Us Holdings, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nestle Health Science Us Holdings, Inc. owns 3 companies in total, including Axcella Health Inc (AXLA) , Aimmune Therapeutics Inc (AIMT) , and Seres Therapeutics Inc (MCRB) .
Insider Ownership Summary of Nestle Health Science Us Holdings, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXLA | Axcella Health Inc | 2020-05-18 | 10 percent owner |
| AIMT | Aimmune Therapeutics Inc | 2018-12-31 | 10 percent owner |
| MCRB | Seres Therapeutics Inc | 2015-06-25 | 10 percent owner |
Nestle Health Science Us Holdings, Inc. Latest Holdings Summary
Nestle Health Science Us Holdings, Inc. currently owns a total of 2 stocks. Among these stocks, Nestle Health Science Us Holdings, Inc. owns 20,216,697 shares of Aimmune Therapeutics Inc (AIMT) as of November 28, 2018, with a value of $697 Million and a weighting of 99.99%. Nestle Health Science Us Holdings, Inc. also owns 172,222 shares of Axcella Health Inc (AXLA) as of May 18, 2020, with a value of $69,044 and a weighting of 0.01%.
Latest Holdings of Nestle Health Science Us Holdings, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2018-11-28 | 20,216,697 | 34.49 | 697,273,880 |
| AXLA | Axcella Health Inc | 2020-05-18 | 172,222 | 0.40 | 69,044 |
Holding Weightings of Nestle Health Science Us Holdings, Inc.
Nestle Health Science Us Holdings, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Nestle Health Science Us Holdings, Inc. has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 4,175,029 shares on November 28, 2018, which cost Nestle Health Science Us Holdings, Inc. around $128 Million.
According to the SEC Form 4 filings, Nestle Health Science Us Holdings, Inc. has made a total of 1 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 77,474 shares on May 18, 2020, which cost Nestle Health Science Us Holdings, Inc. around $9 Million.
Insider Trading History of Nestle Health Science Us Holdings, Inc.
- 1
Nestle Health Science Us Holdings, Inc. Trading Performance
GuruFocus tracks the stock performance after each of Nestle Health Science Us Holdings, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nestle Health Science Us Holdings, Inc. is 18.76%. GuruFocus also compares Nestle Health Science Us Holdings, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Nestle Health Science Us Holdings, Inc. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nestle Health Science Us Holdings, Inc.'s insider trading performs compared to the benchmark.
Performance of Nestle Health Science Us Holdings, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.09 | | | | | |
| Relative Return to S&P 500(%) | 20.06 | | | | | |
Nestle Health Science Us Holdings, Inc. Ownership Network
Nestle Health Science Us Holdings, Inc. Owned Company Details
What does Axcella Health Inc do?
Who are the key executives at Axcella Health Inc?
Nestle Health Science Us Holdings, Inc. is the 10 percent owner of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .
Axcella Health Inc (AXLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axcella Health Inc Insider Transactions
Nestle Health Science Us Holdings, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Nestle Health Science Us Holdings, Inc.. You might contact Nestle Health Science Us Holdings, Inc. via mailing address: C/o Nestle Usa, Inc., 800 North Brand Blvd., Glendale Ca 91203.
Discussions on Nestle Health Science Us Holdings, Inc.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
